CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)

Historical Holders from Q4 2022 to Q3 2025

Symbol
CASI on Nasdaq
Type / Class
Equity / Ordinary Shares
Shares outstanding
20,761,963
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,606,843
Holdings value
$4,327,257
% of all portfolios
0%
Number of holders
21
Number of buys
6
Number of sells
-7
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Panacea Innovation Ltd 22.5% +13% $4,698,042 +$999,856 4,651,527 +27% James Huang 16 Dec 2025
He Wei-Wu 19.1% -19.6% $4,005,190 +$232,300 3,965,535 +6.2% WEI-WU HE, Ph.D. 18 Dec 2025
Chen Zhenfeng M 11% $4,150,370 2,255,636 Chen Zhenfeng 30 Sep 2025
Huang James 13.8% $3,177,509 2,161,571 James Huang 30 Jun 2025
Ho Chi Sing 6.4% $1,995,202 992,638 Quan Zhou 30 Dec 2024
Foresite Capital Fund VI LP 6.3% +24% $1,626,727 +$320,106 979,956 +24.5% Foresite Capital Fund VI LP 30 Sep 2025

Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2,606,843 $4,327,257 +$649,422 $1.66 21
2025 Q2 2,245,168 $2,648,852 -$589,075 $1.18 23
2025 Q1 2,744,278 $5,927,688 +$186,001 $2.16 22
2024 Q4 2,658,168 $7,523,090 -$53,802 $2.83 22
2024 Q3 1,322,529 $8,138,853 +$5,984,886 $6.16 20
2024 Q2 352,170 $1,936,256 +$552,357 $5.5 23
2024 Q1 252,002 $909,576 -$261,433 $3.61 20
2023 Q4 275,894 $1,981,066 -$338,820 $7.16 17
2023 Q3 344,608 $882,628 -$268,771 $2.56 18
2023 Q2 449,838 $1,124,376 -$1,180,810 $2.5 18
2023 Q1 929,752 $2,152,582 +$2,152,350 $2.32 19
2022 Q4 100 $179 +$179 $1.79 1